The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
CD133: molecule of the moment
Abstract
CD133 (prominin‐1) was the first in a class of novel pentaspan membrane proteins to be identified in both humans and mice, and was originally classified as a marker of primitive haematopoietic and neural stem cells. Due to the highly restricted expression of CD133 family molecules on plasma membrane protrusions of epithelial and other cell types, in association with membrane cholesterol, a role in the organization of plasma membrane topology has also recently been assigned to this family. Studies have now confirmed the utility of CD133 as a marker of haematopoietic stem cells for human allogeneic transplantation. In addition, CD133 represents a marker of tumour‐initiating cells in a number of human cancers, and therefore it may be possible to develop future therapies towards targeting cancer stem cells via this marker. The development of such therapies will be aided by a clearer understanding of the molecular mechanisms and signalling pathways that regulate the behaviour of CD133‐expressing cells, and new data outlining the role of Wnt, Notch, and bone morphogenetic protein (BMP) signalling in CD133+ cancer stem cell regulation are discussed within. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., & Maitland, N. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2018 · Cited by 2,820
Direct isolation of human central nervous system stem cells
Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., Tsukamoto, A. S., Gage, F. H., & Weissman, I. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14720 · Cited by 1,849
AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells
Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., Olweus, J., Kearney, J., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5002 · Cited by 1,822
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells
Piccirillo, S. G. M., Reynolds, B. A., Zanetti, N., Lamorte, G., Binda, E., Broggi, G., Brem, H., Olivi, A., Dimeco, F., & Vescovi, A. L. (2006) · Nature · doi:10.1038/nature05349 · Cited by 1,176
Clement, V., Sanchez, P., de Tribolet, N., Radovanovic, I., & Ruiz i Altaba, A. (2007) · Current Biology · doi:10.1016/j.cub.2006.11.033 · Cited by 1,050
Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., Bray, R. A., Waller, E. K., & Buck, D. W. (1997) · Blood · doi:10.1182/blood.v90.12.5013 · Cited by 984
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Fodde, R., & Brabletz, T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.007 · Cited by 785
Ma, S., Lee, T. K., Zheng, B.-J., Chan, K. W., & Guan, X.-Y. (2008) · Oncogene · doi:10.1038/sj.onc.1210811 · Cited by 775
CD133, a novel marker for human prostatic epithelial stem cells
Richardson, G. D., Robson, C. N., Lang, S. H., Neal, D. E., Maitland, N. J., & Collins, A. T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01222 · Cited by 770
Isolation of Renal Progenitor Cells from Adult Human Kidney
Bussolati, B., Bruno, S., Grange, C., Buttiglieri, S., Deregibus, M. C., Cantino, D., & Camussi, G. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62276-6 · Cited by 644
Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors
Fan, X., Matsui, W., Khaki, L., Stearns, D., Chun, J., Li, Y.-M., & Eberhart, C. G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0858 · Cited by 615
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells
Suetsugu, A., Nagaki, M., Aoki, H., Motohashi, T., Kunisada, T., & Moriwaki, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.128 · Cited by 609
Weigmann, A., Corbeil, D., Hellwig, A., & Huttner, W. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12425 · Cited by 608
Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System
Haraguchi, N., Utsunomiya, T., Inoue, H., Tanaka, F., Mimori, K., Barnard, G. F., & Mori, M. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0282 · Cited by 569
CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity
Yin, S., Li, J., Hu, C., Chen, X., Yao, M., Yan, M., Jiang, G., Ge, C., Xie, H., Wan, D., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22476 · Cited by 555
Röper, K., Corbeil, D., & Huttner, W. B. (2000) · Nature Cell Biology · doi:10.1038/35023524 · Cited by 555
Isolation of neural stem cells from the postnatal cerebellum
Lee, A., Kessler, J. D., Read, T.-A., Kaiser, C., Corbeil, D., Huttner, W. B., Johnson, J. E., & Wechsler-Reya, R. J. (2005) · Nature Neuroscience · doi:10.1038/nn1473 · Cited by 486
Corbeil, D., Röper, K., Hellwig, A., Tavian, M., Miraglia, S., Watt, S. M., Simmons, P. J., Peault, B., Buck, D. W., & Huttner, W. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5512 · Cited by 434
Marzesco, A.-M., Janich, P., Wilsch-Bräuninger, M., Dubreuil, V., Langenfeld, K., Corbeil, D., & Huttner, W. B. (2005) · Journal of Cell Science · doi:10.1242/jcs.02439 · Cited by 433
Torrente, Y., Belicchi, M., Sampaolesi, M., Pisati, F., Meregalli, M., D’Antona, G., Tonlorenzi, R., Porretti, L., Gavina, M., Mamchaoui, K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420325 · Cited by 395
Gallacher, L., Murdoch, B., Wu, D. M., Karanu, F. N., Keeney, M., & Bhatia, M. (2000) · Blood · doi:10.1182/blood.v95.9.2813.009k20_2813_2820 · Cited by 322
Prominin: A Story of Cholesterol, Plasma Membrane Protrusions and Human Pathology
Corbeil, D., Röper, K., Fargeas, C. A., Joester, A., & Huttner, W. B. (2001) · Traffic · doi:10.1034/j.1600-0854.2001.020202.x · Cited by 316
Florek, M., Haase, M., Marzesco, A.-M., Freund, D., Ehninger, G., Huttner, W. B., & Corbeil, D. (2005) · Cell and Tissue Research · doi:10.1007/s00441-004-1018-z · Cited by 276
am Esch, J. S., Knoefel, W. T., Klein, M., Ghodsizad, A., Fuerst, G., Poll, L. W., Piechaczek, C., Burchardt, E. R., Feifel, N., Stoldt, V., et al. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0283 · Cited by 244
de Wynter, E. A., Buck, D., Hart, C., Heywood, R., Coutinho, L. H., Clayton, A., Rafferty, J. A., Burt, D., Guenechea, G., Bueren, J. A., et al. (1998) · STEM CELLS · doi:10.1002/stem.160387 · Cited by 209
Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?
Neuzil, J., Stantic, M., Zobalova, R., Chladova, J., Wang, X., Prochazka, L., Dong, L., Andera, L., & Ralph, S. J. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.159 · Cited by 189
Detection of tumor stem cell markers in pancreatic carcinoma cell lines.
Olempska, M., Eisenach, P. A., Ammerpohl, O., Ungefroren, H., Fändrich, F., & Kalthoff, H. (2007) · PubMed · Cited by 183
CD133+ Renal Progenitor Cells Contribute to Tumor Angiogenesis
Bruno, S., Bussolati, B., Grange, C., Collino, F., Graziano, M. E., Ferrando, U., & Camussi, G. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.060498 · Cited by 172
AC133-2, a Novel Isoform of Human AC133 Stem Cell Antigen
Yu, Y., Flint, A., Dvorin, E. L., & Bischoff, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202349200 · Cited by 161
Shmelkov, S. V., Jun, L., St Clair, R., McGarrigle, D., Derderian, C. A., Usenko, J. K., Costa, C., Zhang, F., Guo, X., & Rafii, S. (2004) · Blood · doi:10.1182/blood-2003-06-1881 · Cited by 159
The involvement of endothelial progenitor cells in tumor angiogenesis
Ribatti, D. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00319.x · Cited by 149
Oshima, Y., Suzuki, A., Kawashimo, K., Ishikawa, M., Ohkohchi, N., & Taniguchi, H. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.11.027 · Cited by 137
Stem cells and cancer: an intimate relationship
Burkert, J., Wright, N., & Alison, M. R. (2006) · The Journal of Pathology · doi:10.1002/path.2016 · Cited by 134
Self-citationSomatic Stem Cell Marker Prominin‐1/CD133 Is Expressed in Embryonic Stem Cell–Derived Progenitors
Kania, G., Corbeil, D., Fuchs, J., Tarasov, K. V., Błyszczuk, P., Huttner, W. Β., Boheler, K. R., & Wobus, A. M. (2005) · Stem Cells · doi:10.1634/stemcells.2004-0232 · Cited by 134
Isolation and characterization of murine neural stem/progenitor cells based on Prominin-1 expression
Corti, S. P., Nizzardo, M., Nardini, M., Donadoni, C., Locatelli, F., Papadimitriou, D. A., Salani, S., Bo, R. D., Ghezzi, S., Strazzer, S., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.021 · Cited by 130
Fargeas, C. A., Joester, A., Missol‐Kolka, E., et al. (2004) · Journal of Cell Science · doi:10.1242/jcs.01315 · Cited by 126
Fargeas, C. A., Corbeil, D., & Huttner, W. Β. (2003) · Stem Cells · doi:10.1634/stemcells.21-4-506 · Cited by 113
Nomenclature of prominin‐1 (CD133) splice variants – an update
Fargeas, C. A., Huttner, W. Β., & Corbeil, D. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00825.x · Cited by 107
In vitro characterization of a human neural progenitor cell coexpressing SSEA4 and CD133
Barraud, P., Stott, S., Møllgård, K., Parmar, M., & Björklund, A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21116 · Cited by 96
Corbeil, D., Röper, K., Weigmann, A., & Huttner, W. Β. (1998) · Blood · doi:10.1182/blood.v91.7.2625 · Cited by 95
Progenitor Marker CD133 mRNA Is Elevated in Peripheral Blood of Cancer Patients with Bone Metastases
Mehra, N., Penning, M. T., Maas, J., Beerepoot, L. V., van Daal, N., van Gils, C. H., Giles, R. H., & Voest, E. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0422 · Cited by 85
Florek, M., Bauer, N., Janich, P., Wilsch‐Bräuninger, M., Fargeas, C. A., Marzesco, A., Ehninger, G., Thiele, C., Huttner, W. Β., & Corbeil, D. (2006) · Cell and Tissue Research · doi:10.1007/s00441-006-0324-z · Cited by 75
Large-scale isolation of CD133+ progenitor cells from G-CSF mobilized peripheral blood stem cells
Gordon, P. R., Leimig, T., Babarin-Dorner, A., Houston, J., Holladay, M. S., Mueller, I., Geiger, T. L., & Handgretinger, R. (2003) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703792 · Cited by 70
Liang, Y., Zhou, Z.-H., Ping, Y., Chen, J., Yao, X., Feng, H., Lu, J.-Y., Wang, J. M., & Bian, X. (2007) · Modern Pathology · doi:10.1038/modpathol.3800942 · Cited by 60
Nikolova, T., Wu, M., Brumbarov, K., Alt, R., Opitz, H., Boheler, K. R., Cross, M. A., & Wobus, A. M. (2006) · Differentiation · doi:10.1111/j.1432-0436.2006.00119.x · Cited by 43
Cellular pathways to β‐cell replacement
Fellous, T. G., Guppy, N., Brittan, M., & Alison, M. R. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.692 · Cited by 25
Self-citationLu, X., Baudouin, S., Gillespie, J., Anderson, J. J., & Dickinson, A. M. (2007) · Cytotherapy · doi:10.1080/14653240701247853 · Cited by 10
Husain, S. M., Shou, Y., Sorrentino, B. P., & Handgretinger, R. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00679.x · Cited by 5
(2003) · PubMed
Cited by
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation
Zhu, L., Gibson, P., Currle, D. S., Tong, Y., Richardson, R. J., Bayazitov, I. T., Poppleton, H., Zakharenko, S., Ellison, D. W., & Gilbertson, R. J. (2009) · Nature · doi:10.1038/nature07589 · Cited by 668
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells
Baba, T., Convery, P. A., Matsumura, N., Whitaker, R. S., Kondoh, E., Perry, T., Huang, Z., Bentley, R. C., Mori, S., Fujii, S., et al. (2009) · Oncogene · doi:10.1038/onc.2008.374 · Cited by 419
CD133 expression is an independent prognostic marker for low survival in colorectal cancer
Horst, D., Kriegl, L., Engel, J., Kirchner, T., & Jung, A. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604664 · Cited by 311
Metadata
- Authors
- Mizrak, D., Brittan, M., & Alison, M.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2007-12-07
- Volume
- 214
- Issue
- 1
- Pages
- 3-9
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2019950666
- Cited by
- 520
- References
- 55
- FWCI
- 22.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.